
-
Louboutin taps Jaden Smith to lead well-heeled shoemaker's men's line
-
Pakistan beat UAE to set up India rematch in Asia Cup
-
US Fed makes first rate cut of 2025 over employment risks
-
US sprint star Kerley joins drug-fueled Enhanced Games
-
Decaying body found in US rapper's Tesla identified as teen girl
-
Flick backs 'unbelievable' Rashford to shine in Yamal absence
-
Mourinho poised for Benfica return after Lage sacking
-
US Fed makes first rate cut of 2025 on employment risks
-
Fired US health agency chief says was under RFK Jr 'pressure' to ignore science
-
Brazil's Bolsonaro adds skin cancer to medical woes
-
Colombia vows to fight drug trade 'with or without' the US
-
Germany's Merz criticises festival for axing Israeli conductor
-
Thousands protest in London over Trump UK visit
-
Fired US health agency chief testifies on pressure to 'replace evidence with ideology'
-
Palestinians flee Gaza City in face of deadly Israeli offensive
-
England take Salt path to victory over Ireland in first T20
-
French strikes hit Bayeux Tapestry transfer ahead of UK loan
-
New York officials sink Times Square casino bid
-
Canada central bank cuts key lending rate citing Trump tariffs
-
Pakistan Asia Cup match belatedly goes ahead amid India handshake row
-
Nader pulls off shock in 1,500 metres, Moon rises to pole vault challenge at worlds
-
Ex-US climate envoy: Trump threatening 'consensus science' worldwide
-
EU proposes action on Israel trade and ministers over Gaza
-
US Treasury official expected to be named IMF's second-in-command: source
-
Man City 'apparently' not Champions League contenders: Guardiola
-
EU says India's Russia links jeopardise closer ties
-
Ukraine reach BJK Cup semi-finals for first time
-
Benjamin sets up 'historic' hurdles showdown with Warholm and Dos Santos
-
Milan-Cortina bobsleigh track 'surpasses expectations', say Winter Olympics organisers
-
Stocks, dollar calm ahead of expected US rate cut
-
Nvidia CEO disappointed over China chip ban report
-
Portugal's Isaac Nader wins world men's 1,500m gold
-
France launches appeal to acquire Proust's 'madeleine' writings
-
East Timor to scrap MP pensions and SUVs after protests
-
Van Niekerk enjoys second wind in Tokyo after injury nightmare
-
American Moon wins third straight world pole vault gold
-
King gives Trump royal welcome on UK state visit
-
Man Utd post sixth straight annual loss despite record revenues
-
Australian teen Gout Gout revels in world championships debut
-
AI may boost global trade value by nearly 40%: WTO
-
New Zealand star Miller out of Women's Rugby World Cup semi-final
-
Lyles and Gout Gout advance to world 200m semi-finals
-
S.Africa commission begins probe into alleged links between politics and crime
-
PSG women in audacious bid to sign Barca's Putellas
-
Jefferson-Wooden eases into world 200m semis and sets sights on being next Fraser-Pryce
-
Germany's Merz vows 'autumn of reforms' in turbulent times
-
EU says India's Russian oil purchases, military drills hinder closer ties
-
Gold worth 600,000 euros stolen in Paris museum heist
-
Top music body says AI firms guilty of 'wilful' copyright theft
-
Trump gets royal treatment on UK state visit

'Synthetic embryo' breakthrough but growing human organs far off
Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for transplantation remains distant.
The breakthrough was hailed as a major step forward, though some experts said the result could not fully be considered to be embryos and warned of future ethical considerations.
In research published in the journal Cell this week, scientists at the Weizmann Institute of Science in Israel described mouse stem cells self-assembling into embryo-like structures in the lab.
The research built upon 2018 research that had a bundle of mouse stem cells self-organised into something resembling the beginnings of an embryo -- but with far fewer cells.
The Weizmann team led by Palestinian stem cell scientist Jacob Hanna went much further.
They started by collecting cells from the skin of mice, then made them artificially return to the state of stem cells.
The stem cells were then placed in a special incubator, which continuously moved to mimic a mother's womb.
The vast majority of the cells failed to form anything.
But 50 -- 0.5 percent of the 10,000 total -- collected themselves into spheres, then embryo-like structures, the researchers said.
After eight days -- around a third of the 20-day mouse gestation period -- there were early signs of a brain and a beating heart, they added.
They were described as 95 percent similar to normal mouse embryos.
"The embryo is the best organ-making machine and the best 3D bioprinter -- we tried to emulate what it does," Hanna said in a Weizmann statement.
- 'Not embryos' -
While they were the most advanced synthetic embryo-like structures ever grown, some scientists not involved in the research warned against calling them "embryos".
"These are not embryos," French stem cell scientist Laurent David told AFP.
"Until proven otherwise, they do not result in a viable individual capable of reproducing," he added.
He preferred to call them embryoids, the name for a group of cells that resemble an embryo, emphasising that they showed only the very beginnings of organs.
However, David welcomed the "very convincing" research, which he said could allow further experiments to understand exactly how organs form.
Hanna said the team's "next challenge is to understand how stem cells know what to do -- how they self-assemble into organs and find their way to their assigned spots inside an embryo".
- Ethical implications -
If human organs could one day be grown in a lab, it could provide life-saving transplants to thousands of people every year without the need for donors.
There has been progress in this new field -- several years ago researchers managed to develop an artificial intestine in the lab that could be implanted into a mouse.
For humans, however, such organ implants remain science fiction.
Still, Hanna has founded a company, Renewal Bio, that aims to find a way to use the technology for therapeutic purposes.
Researchers not involved in the study said it was very early to consider using such a technique for humans.
Alfonso Martinez Arias of Spain's Pompeu Fabra University said the breakthrough "opens the door to similar studies with human cells, though there are many regulatory hoops to get through first and, from the point of view of the experiments, human systems lag behind mouse systems".
And aiming to get similar results from human cells will likely open an ethical can of worms.
"Although the prospect of synthetic human embryos is still distant, it will be crucial to engage in wider discussions about the legal and ethical implications of such research," James Briscoe of Britain's Francis Crick Institute said.
H.E.Young--AMWN